During the past decade, NEURO-CARE Sp. z o.o. Sp. Komandytowa conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 10 clinical trials were completed, i.e. on average, 47.6% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NEURO-CARE Sp. z o.o. Sp. Komandytowa" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "ACADIA Pharmaceuticals Inc." with 3 trials sponsored, "Theravance Biopharma" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Impax Laboratories, LLC" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NEURO-CARE Sp. z o.o. Sp. Komandytowa" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "NEURO-CARE Sp. z o.o. Sp. Komandytowa" are "Alzheimer Disease" (5 trials), "Alzheimer's Disease" (3 trials), "Symptomatic Neurogenic Orthostatic Hypotension" (3 trials), "Multiple Sclerosis" (2 trials) and "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials). Many other conditions were trialed in "NEURO-CARE Sp. z o.o. Sp. Komandytowa" in a lesser frequency.

Most popular intervention types in "NEURO-CARE Sp. z o.o. Sp. Komandytowa" are "Drug" (22 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ocrelizumab" (4 trials), "ampreloxetine" (3 trials), "Donanemab" (2 trials) and "Gantenerumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "NEURO-CARE Sp. z o.o. Sp. Komandytowa" are 22 trials for "All" genders.

Currently, there are NaN active trials in "NEURO-CARE Sp. z o.o. Sp. Komandytowa". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in NEURO-CARE Sp. z o.o. Sp. Komandytowa, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in NEURO-CARE Sp. z o.o. Sp. Komandytowa, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

NEURO-CARE Sp. z o.o. Sp. Komandytowa has several departments that took part in Clinical trials: "Neuro-Care Gabriela Klodowska" - 2 trials